Related references
Note: Only part of the references are listed.Parkinsonian Rotenone Mouse Model: Reevaluation of Long-Term Administration of Rotenone in C57BL/6 Mice
Masatoshi Inden et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Joo-Ho Shin et al.
CELL (2011)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
A Tale on Animal Models of Parkinson's Disease
Erwan Bezard et al.
MOVEMENT DISORDERS (2011)
DOPAMINE OXIDATION FACILITATES ROTENONE-DEPENDENT POTENTIATION OF N-METHYL-D-ASPARTATE CURRENTS IN RAT SUBSTANTIA NIGRA DOPAMINE NEURONS
Y. -N. Wu et al.
NEUROSCIENCE (2011)
Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation
Bobby Thomas et al.
PLOS ONE (2011)
Early Presymptomatic and Long-Term Changes of Rest Activity Cycles and Cognitive Behavior in a MPTP-Monkey Model of Parkinson's Disease
Julien Vezoli et al.
PLOS ONE (2011)
Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3
Phillip M. Rappold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Paraquat and Parkinson's disease
C. Berry et al.
CELL DEATH AND DIFFERENTIATION (2010)
Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration
Anil Kachroo et al.
EXPERIMENTAL NEUROLOGY (2010)
Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration
Jun Peng et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease
Chris C. Tang et al.
JOURNAL OF NEUROSCIENCE (2010)
Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study
Javier Blesa et al.
NEUROBIOLOGY OF DISEASE (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
Francisco Pan-Montojo et al.
PLOS ONE (2010)
Neuroanatomical Study of the A11 Diencephalospinal Pathway in the Non-Human Primate
Quentin Barraud et al.
PLOS ONE (2010)
The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis
W. Michael Panneton et al.
PLOS ONE (2010)
Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System
Francisco J. Pan-Montojo et al.
Jove-Journal of Visualized Experiments (2010)
Nicotinic Receptor Stimulation Protects Nigral Dopaminergic Neurons in Rotenone-induced Parkinson's Disease Models
Hiroki Takeuchi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
Thomas S. Guillot et al.
MOLECULAR NEUROBIOLOGY (2009)
No Lewy Pathology in Monkeys with Over 10 Years of Severe MPTP Parkinsonism
Glenda Halliday et al.
MOVEMENT DISORDERS (2009)
Serotonin and Parkinson's Disease: On Movement, Mood, and Madness
Susan H. Fox et al.
MOVEMENT DISORDERS (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
A highly reproducible rotenone model of Parkinson's disease
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2009)
The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway
Mei Cui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Value of genetic models in understanding the cause and mechanisms of Parkinson's disease
Darren J. Moore et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2008)
Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis
Thomas S. Guillot et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons
Danling Wang et al.
MOLECULAR NEURODEGENERATION (2008)
The 6-hydroxydopamine model: News from the past
Fabio Blandini et al.
PARKINSONISM & RELATED DISORDERS (2008)
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
William J. Burke et al.
ACTA NEUROPATHOLOGICA (2008)
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery
Stephanie Mounayar et al.
BRAIN (2007)
Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease
Grant Anderson et al.
EXPERIMENTAL NEUROLOGY (2007)
Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone
Masatoshi Inden et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Non-motor symptoms of Parkinson's disease: diagnosis and management
KR Chaudhuri et al.
LANCET NEUROLOGY (2006)
Reactive oxygen and nitrogen species: Weapons of neuronal destruction in models of Parkinson's disease
S Przedborski et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Parkinson-like syndrome induced by continuous MPTP infusion:: Convergent roles of the ubiquitin-proteasome system and α-synuclein
F Fornai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets
MM Iravani et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism. I. Effects of task complexity
M Pessiglione et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
A fetal risk factor for Parkinson's disease
BK Barlow et al.
DEVELOPMENTAL NEUROSCIENCE (2004)
Stages in the development of Parkinson's disease-related pathology
H Braak et al.
CELL AND TISSUE RESEARCH (2004)
The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA
M Alam et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
TB Sherer et al.
EXPERIMENTAL NEUROLOGY (2003)
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
W Dauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat
AL McCormack et al.
NEUROBIOLOGY OF DISEASE (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Animal models of Parkinson's disease
R Betarbet et al.
BIOESSAYS (2002)
The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice -: Paraquat and α-synuclein
AB Manning-Bog et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety
S Przedborski et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
M Vila et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Increased striatal dopamine turnover following acute administration of rotenone to mice
C Thiffault et al.
BRAIN RESEARCH (2000)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?
M Thiruchelvam et al.
BRAIN RESEARCH (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
NW Kowall et al.
NEUROREPORT (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
Share Paper
